Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America (2019)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.arteri.2018.06.002
- Subjects: PERICÁRDIO; TECIDO ADIPOSO; DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; AMÉRICA LATINA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinica e investigacion en arteriosclerosis
- ISSN: 0214-9168
- Volume/Número/Paginação/Ano: v. 31, n. 1, p. 15-22, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LIMA-MARTINEZ, Marcos M et al. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America. Clinica e investigacion en arteriosclerosis, v. 31, n. 1, p. 15-22, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.arteri.2018.06.002. Acesso em: 17 fev. 2026. -
APA
Lima-martinez, M. M., Colmenares, L., Campanelli, Y., Paoli, M., Rodney, M., Santos Filho, R. D. dos, & Iacobellis, G. (2019). Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America. Clinica e investigacion en arteriosclerosis, 31( 1), 15-22. doi:10.1016/j.arteri.2018.06.002 -
NLM
Lima-martinez MM, Colmenares L, Campanelli Y, Paoli M, Rodney M, Santos Filho RD dos, Iacobellis G. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America [Internet]. Clinica e investigacion en arteriosclerosis. 2019 ; 31( 1): 15-22.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.arteri.2018.06.002 -
Vancouver
Lima-martinez MM, Colmenares L, Campanelli Y, Paoli M, Rodney M, Santos Filho RD dos, Iacobellis G. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America [Internet]. Clinica e investigacion en arteriosclerosis. 2019 ; 31( 1): 15-22.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.arteri.2018.06.002 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1016/j.arteri.2018.06.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
